Dozens of psychedelic startup companies are racing to begin selling mind-expanding drugs for depression and other mental health conditions, riding a wave of promising research and media hype
Dozens of psychedelic startup companies are racing to begin selling mind-expanding drugs for depression and other mental health conditions, riding a wave of promising research and media hype